Related Experiment Video
Updated: Sep 19, 2025

02:22
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
529
Treatment Algorithm Suggestion for Hailey-Hailey Disease
Nefeli Giannopoulou1, Olivia Mathot1, Bertrand Richert1
1Dermatology Department, Université Libre de Bruxelles, University Hospital Brugmann and Saint-Pierre, Brussels, Belgium.
Journal of Cutaneous Medicine and Surgery
|June 16, 2025
Summary
Hailey-Hailey disease, a rare genetic skin disorder, presents challenges due to limited treatment options. This review systematically analyzes current and emerging therapies to guide clinical decisions for this chronic condition.
Area of Science:
- Dermatology
- Genetics
- Rare Diseases
Background:
- Hailey-Hailey disease is a rare autosomal dominant genodermatosis affecting keratinocyte adhesion.
- Caused by ATP2C1 gene mutations, it clinically manifests as blisters, erosions, and fissures in flexural areas.
- The condition follows a chronic relapsing course with limited therapeutic options.
Purpose of the Study:
- To systematically review established and emerging treatments for Hailey-Hailey disease.
- To assess the evidence supporting various therapeutic options.
- To propose a therapeutic algorithm for clinical decision-making.
Main Methods:
- Systematic literature analysis of Hailey-Hailey disease treatments.
- Evaluation of evidence strength for each treatment modality.
- Focus on both pharmacological and procedural therapies.
Main Results:
- A wide range of treatments exist, including topical, systemic, and procedural options.
- Evidence for treatment effectiveness and safety is often limited due to a lack of large trials.
- Non-pharmacological measures are crucial for managing the disease.
Conclusions:
- Developing evidence-based guidelines for Hailey-Hailey disease is challenging.
- A comprehensive understanding of treatment evidence is needed to guide clinical practice.
- This review aims to provide a structured approach to managing Hailey-Hailey disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
67
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
67
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28

